The EPS projection of Ophthotech Corporation (NASDAQ:OPHT) for quarter ended 2016-09-30 is $-1.17. Last week, the projection for EPS was $-1.17 against target of $-1.17, a month earlier. While 2-months ago, this projection was $-1.17 versus forecast of $-1.17a quarter months earlier, posting a deviation of 0%.
Ophthotech Corporation (NASDAQ:OPHT) posted that 18 days earlier, the share price was revised 1 times on upside. In addition, negative revisions were 1.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 0. While in last 120 and 90 days, positive revisions were 2, and 2, correspondingly.
The per-share earnings downgrade for Ophthotech Corporation (NASDAQ:OPHT) in the preceding 30 and 120 were 0 and 2. While in 60 and 90 days were 0, and 2, in that order.
Ophthotech Corporation (NASDAQ:OPHT) EPS target was $-1.17 for the quarter closed 1. It was based on 5 calls. As on 2016-05-04 the EPS was $-1.03. The change was $0.29, posting a deviation of 21.97%. The price projections gave a standard deviation of 0.12.
Quarterly Sales Estimates
Ophthotech Corporation (NASDAQ:OPHT) sales prediction for the fiscal 2016 stands at $19.36 and the median estimate is at $6.48. Almost 3 analysts gave sales target.
Among this, the highest sales estimate is $49.5 while the lowest target is $2.1 showing standard deviation of 26.193%.
As many as 3 analysts have positive sales targets revision while 3 reduced sales estimates, posting a deviation of 0%.
Last month, 3 experts have positive sales number revision. Also, 3 research groups lowered the sales projections, posting a deviation of 0%.
A quarter ago, 3 hiked sales target and 3 reduced sales forecast, posting a deviation of 0%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...